alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Growth Hotel
Investors 1996 Year-End 10-K and is qualified in its entirety by reference to
such 10-K filing.
</LEGEND>
<CIK> 0000769129
<NAME> GROWTH HOTEL INVESTORS
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           4,644
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                          24,577
<DEPRECIATION>                                 (9,675)
<TOTAL-ASSETS>                                  28,422
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                          5,412
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      22,445
<TOTAL-LIABILITY-AND-EQUITY>                    28,422
<SALES>                                              0
<TOTAL-REVENUES>                                 9,831
<CGS>                                                0
<TOTAL-COSTS>                                    7,273
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 594
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,593
<EPS-PRIMARY>                                    65.36<F2>
<EPS-DILUTED>                                        0
<FN>
<F1>Registrant has an unclassified balance sheet.
<F2>Mutliplier is 1.
</FN>
        

</TABLE>
[Federal Register Volume 66, Number 117 (Monday, June 18, 2001)]
[Notices]
[Page 32794]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-15194]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric Administration

[I.D. 060601A]


Marine Mammals; File No.605-1607-00

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Issuance of permit.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that The Whale Center of New England, 
P.O. Box 159 , Gloucester, MA 01931-0159 (PI: Mason Weinrich) has been 
issued a permit to take four large whale species for purposes of 
scientific research.

ADDRESSES: The permit and related documents are available for review 
upon written request or by appointment in the following office(s):
    Permits and Documentation Division, Office of Protected Resources, 
NMFS, 1315 East-West Highway, Room 13705, Silver Spring, MD 20910; 
phone (301) 713-2289; fax (301) 713-0376;
    Northeast Region, NMFS, One Blackburn Drive, Gloucester, MA 01930-
2298; phone (978) 281-9200; fax (978) 281-9371;
    Southeast Region, NMFS, 9721 Executive Center Drive North, St. 
Petersburg, FL 33702-2432; phone (727) 570-5301; fax (727) 570-5320.

FOR FURTHER INFORMATION CONTACT: Tammy Adams or Ruth Johnson (301) 713-
2289.

SUPPLEMENTARY INFORMATION: On December 27, 2000, notice was published 
in the Federal Register (65 FR 81844) that a request for a scientific 
research permit to take four large whale species had been submitted by 
the above-named organization. The requested permit has been issued 
under the authority of the Marine Mammal Protection Act of 1972, as 
amended (16 U.S.C. 1361 et seq.), the Regulations Governing the Taking 
and Importing of Marine Mammals (50 CFR part 216), the Endangered 
Species Act of 1973, as amended (ESA; 16 U.S.C. 1531 et seq.), the 
regulations governing the taking, importing, and exporting of 
endangered and threatened species (50 CFR parts 222-226), and the Fur 
Seal Act of 1966, as amended (16 U.S.C. 1151 et seq.).
    Issuance of this permit, as required by the ESA, was based on a 
finding that such permit (1) was applied for in good faith, (2) will 
not operate to the disadvantage of the endangered species which is the 
subject of this permit, and (3) is consistent with the purposes and 
policies set forth in section 2 of the ESA.

    Dated: June 11, 2001.
Ann D. Terbush,
Chief, Permits and Documentation Division, Office of Protected 
Resources, National Marine Fisheries Service.
[FR Doc. 01-15194 Filed 6-15-01; 8:45 am]
BILLING CODE 3510-22-S
Page 1 

Commodity Futures Trading Commission 

CEA CASES 

NAME: CHARLES VOJTEK 

CITATION: 14 Agric. Dec. 347 

DOCKET NUMBER: 43 

DATE: MAY 3, 1955 

DOCUMENT TYPE: ORDER REMOVING SUSPENSION OF TRADING PRIVILEGES 

AGRICULTURE DECISIONS

BEFORE THE SECRETARY OF AGRICULTURE

UNITED STATES DEPARTMENT OF AGRICULTURE

(No. 4256) 

In re CHARLES VOJTEK. CEA Docket No. 43. Decided May 3, 1955. 

Termination of Suspension of Trading Privileges

Where respondent was denied trading privileges (7 Agric. Dec. 386 (7 A.D. 

386)) but has since made full restitution, and it is deemed that the public 

interest requires no further suspension, respondent's request for restitution is 

granted. 

Mr. Rodger R. Kaufmann, Administrator, Commodity Exchange Authority, for 

Commodity Exchange Authority. Mr. Charles Vojtek, of Westchester, Illinois, 

respondent, pro se. 

Decision by Thomas J. Flavin, Judicial Officer

ORDER REMOVING SUSPENSION OF TRADING PRIVILEGES

On May 26, 1948, an order was entered in this proceeding under the Commodity 

Exchange Act (7 U.S.C. Chapter 1) directing contract markets to refuse the 

respondent all trading privileges thereon "until further order of the Secretary 

of Agriculture." The respondent has, in effect, requested the issuance of an 

order terminating the suspension of his trading privileges. The request states 

that the respondent has made full restitution. The Commodity Exchange Authority 

has filed an answer to the request stating, in effect, that it appears that the 

respondent has made restitution and that it believes that reinstatement of 

trading privileges is justified. 

Since the respondent's trading privileges have been suspended for nearly 

seven years, the public interest requires no further suspension, and the 

respondent's request for restoration is granted. 

Accordingly, all contract markets are hereby notified, as provided by the 

order of May 26, 1948, that they need no longer refuse trading privileges to 

Charles Vojtek. 

A copy hereof shall be served by registered mail upon the respondent and upon 

all contract markets. 

LOAD-DATE: June 8, 2008 
Page 2
No. 400.

#### Magnolia Petroleum Co. et al. *v.*Walker, Commissioner of the General Land Office.

October 14, 1935.

*Messrs. George E. Elliott*and *Walace Hawkins*for petitioners.

*Mr. Scott Gaines*for respondent.

Petition for writ of certiorari to the Supreme Court of Texas denied.
<PAGE>

                                   EXHIBIT 10.20

December 16, 1996

Re:  Development and License Agreement between Pharmacia S.p.A.
     ("Pharmacia") and PDT, Inc. ("PDTI") dated July 1st, 1995, as amended July
     25, 1995, September 11, 1995, March 20, 1996, July 10, 1996 and August 12,
     1996 ("License Agreement") and the Product Supply Agreement dated July 1,
     1995, amended September 11, 1995 and March 20, 1996 ("Product Supply
     Agreement")

Pharmacia and PDTI have amended the License Agreement to include the field of
Ophthalmology, and now wish to amend the Product Supply Agreement with respect
to the field of Ophthalmology.

Pharmacia and PDTI agree to amend the Product Supply Agreement according to the
following terms and conditions:

1.   WHEREAS CLAUSE. The third WHEREAS clause on page 1 shall be deleted and
replaced by:

     "WHEREAS, PDTI and Pharmacia have entered into a Development and License
     Agreement, dated July 1, 1995, as amended (hereinafter "License"), wherein
     Pharmacia acquired exclusive rights to develop, use and sell photoreactive
     tin ethyl etiopurpurin for treatment and diagnosis in the fields of
     oncology, urology, dermatology and ophthalmology; and

     WHEREAS, Pharmacia has sublicensed its license rights in the field of
     Ophthalmology to its affiliate, Pharmacia & Upjohn AB ("P&U AB"), whereby,
     in respect to such Field, such affiliate shall make all royalty and other
     payments, exercise all rights and perform all obligations directly to PDT;
     and"

2.   SNET2 CONCENTRATION. Consistent with a prior amendment made to the License,
the references to ***** mg of SnET2 per ***** ml of emulsion" in Sections 3.05
and 3.06 shall be changed to "***** mg of SnET2 per ***** ml of emulsion."

     3.   *****

4.   P&U AB AS SUBLICENSEE.   The following new Section 15.10 shall be added:

               15.10     SUPPLY TO P&U AB. Pharmacia intends to sublicense its
     rights in the field of Ophthalmology to its Affiliate, P&U AB. In respect
     to such field, the parties intend for such Affiliate to order all Product,
     make all Transfer Price and other payments, exercise all rights and perform
     all obligations under this Agreement directly to PDT.

*****Confidential Treatment Requested

<PAGE>

In all other respects, the Product Supply Agreement is hereby ratified,
confirmed, and approved.


     IN WITNESS WHEREOF, the parties hereto have caused this Product Supply
Agreement to be executed in duplicate by their respective officers duly
authorized as of the date first above written.


PDT, INC.

By  /s/ David E. Mai
  -------------------------------
Name:  David E. Mai

Title:  President



PHARMACIA & UPJOHN S.p.A.

By  /s/ Lamberto Andreotti
  -------------------------------
Name:  Lamberto Andreotti

Title:  Managing Director



PHARMACIA & UPJOHN AB

By  /s/ Goran Petterson                      By  /s/ Mats Lidgard
  -------------------------------              -------------------------------
Name: Goran Petterson                        Name: Mats Lidgard

Title: VP Ophthalmology                      Title: VP Legal Affairs
Exhibit 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

      We hereby consent to the incorporation by reference into the previously
filed Registration Statements on Form S-8 (Registration Nos. 333-38022 and
333-50500) of TTR Technologies, Inc.("TTR") of our report dated March 14, 2001
relating to the financial statements which appear in TTR's Annual Report on Form
10-K for the year ended December 31, 2000, as amended.


/s/ Brightman Almagor & Co.

Certified Public Accountants (Israel)
A member of Deloitte & Touche

Tel-Aviv, Israel
July 13, 2001
<PAGE>   1

                                  EXHIBIT 11.1

                                       67


<PAGE>   2



                       COMPUTATION OF EARNINGS PER SHARE
   (ALL MONEY AMOUNTS STATED IN THOUSANDS OF DOLLARS EXCEPT PER SHARE DATA)

<TABLE>
<CAPTION>
                                                                                                        1996

                                                                                                Shares             Amount
<S>                                                                                           <C>            <C>       
Weighted average number of shares and net income applicable to common stock ......            11,287,579     $ 5,174.00

Stock Options, in equivalent shares under the treasury stock method, primary .....               292,590       
                                                                                              ----------     ----------
                                                                                              11,580,169       5,174.00
                                                                                              ----------     ----------
Per share, primary ...............................................................                           $     0.45

Stock options, in equivalent shares under the treasury stock method, fully diluted                18,618       
                                                                                              ----------               

                                                                                              11,598,787     $ 5,174.00
                                                                                              ==========     ==========

Per share, fully diluted .........................................................                           $     0.45
                                                                                                             ==========
</TABLE>



                                       68
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Docket No. RP99-190-003]

Take notice that on May 2, 2001, National Fuel Gas Distribution Corporation (National Fuel Distribution) filed its final report in compliance with the Commission's order dated March 30, 2000, in Docket No. RP99-190-001. The filing reports that National Fuel Distribution will be able to operate without a waiver of the shipper must have title policy following November 1, 2000 for parts of its upstream capacity and following April 1, 2001 for all of its upstream capacity.

Any person desiring to protest said filing should file a protests with the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426, in accordance with Section 385.211 of the Commission's Rules and Regulations. All such protests must be filed on or before June 19, 2001. Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceedings. Copies of this filing are on file with the Commission and are available for public inspection for public inspection in the Public Reference Room. This filing may be viewed on the web at http://www.ferc.fed.us/​online/​rims.htm (call 202-208-2222 for assistance). Comments, protests and interventions may be filed electronically via the internet in lieu of paper. See, 18 CFR 385.2001(a)(1)(iii) and the instructions on the Commission's web site at http://www.ferc.fed.us/​efi/​doorbell.htm.

David P. Boergers,

Secretary.

[FR Doc. 01-15226 Filed 6-15-01; 8:45 am]

BILLING CODE 6717-01-M
#### CRATERS & FREIGHTERS, a Colorado corporation, Plaintiff—Appellee, v. Fred BENZ; Kathy Benz, Defendants—Appellants, and Daisychain Enterprises, a California corporation, Defendant.

No. 10-16004.

United States Court of Appeals, Ninth Circuit.

*720Submitted Dec. 19, 2011.*

Filed Jan. 11, 2012.

Brian B. Beckwith, Esquire, Law Office of Brian Beckwith, Palo Alto, CA, for Plaintiff-Appellee.

Fred Benz, Eagle, ID, pro se.

Kathy Benz, Eagle, ID, pro se.

Before: GOODWIN, WALLACE, and McKEOWN, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Fred and Kathy Benz appeal pro se from the district court’s default judgment in this action alleging trademark infringement, copyright infringement, and related claims. We have jurisdiction under 28 U.S.C. § 1291. We review de novo the issue of whether a party has waived a defense, *Owens v. Kaiser Found. Health Plan, Inc.,*244 F.3d 708, 713 (9th Cir.2001), and we affirm.

The district court properly concluded that the Benzes waived their defense of insufficient service of process based on their litigation conduct. *See Peterson v. Highland Music, Inc.,*140 F.3d 1313, 1317-18 (9th Cir.1998) (defenses, such as lack of personal jurisdiction, may be waived as a result of a party’s litigation conduct, including when the party raises the defense but does not pursue it further until an adverse decision on the merits).

The Benzes’ remaining contentions are unavailing.

AFFIRMED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
**EXHIBIT
      32.2**







**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**






Pursuant
      to 18 U.S.C. §1350 (adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002),
      I, the undersigned Chief Financial Officer of Aftermarket Technology Corp.
      (the
      "Company"), hereby certify that to the best of my knowledge the Annual Report
      on
      Form 10-K of the Company for the year ended December 31, 2005 (the "Report")
      fully complies with the requirements of section 13(a) or 15(d) of the Securities
      Exchange Act of 1934, as amended, and that information contained in the Report
      fairly presents, in all material respects, the financial condition and results
      of operations of the Company.







Date:
      March 1, 2006








/s/
                Todd R. PetersTodd
                R. Peters, Chief Financial Officer








This
      certification will not be deemed “filed” for purposes of Section 18 of the
      Exchange Act, or otherwise subject to the liability of that section. This
      certification will not be deemed to be incorporated by reference into any filing
      under the Securities Act or the Exchange Act, except to the extent that the
      registrant specifically incorporates it by reference.
Page 1 

Commodity Futures Trading Commission 

CEA CASES 

NAME: EDWARD R. BYER, JOEL STARRELS, JAMES T. MCKERR AND COMPANY, JAMES T. 

MCKERR, CHARLES J. MCKERR, AND GILBERT D. MATHY 

CITATION: 13 Agric. Dec. 1144 

DOCKET NUMBER: 62 

DATE: NOVEMBER 10, 1954 

DOCUMENT TYPE: CORRECTION AND DELETION 

NOTE: CORRECTS SYLLABUS REPORTED IN 13 AGRIC. DEC. 1051 

CORRECTION AND DELETION 

In re EDWARD R. BYER, STARRELS, MCKERR, MCKERK, AND MATHY. 

CEA Docket No. 62. Decided November 10, 1954. 13 Agric. Dec. 1051 (13 A.D. 

1051). 

The syllabus published in the 1954 November issue of the Agriculture 

Decisions in connection with this case, which states that trader-respondent 

admitted trading in futures in excess of limits and concealing such transactions 

and that the other respondents admitted such concealment and submission of false 

reports, is in error and is hereby withdrawn, said respondents having admitted 

only jurisdictional facts. 

LOAD-DATE: June 16, 2008 
Page 2
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1495 Reported in House (RH)]

                                                 House Calendar No. 209
111th CONGRESS
  2d Session
H. RES. 1495

                          [Report No. 111-519]

Providing for consideration of the bill (H.R. 5618) to continue Federal 
unemployment programs, and waiving a requirement of clause 6(a) of rule 
XIII with respect to consideration of certain resolutions reported from 
                        the Committee on Rules.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 30, 2010

   Mr. Cardoza, from the Committee on Rules, reported the following 
resolution; which was referred to the House Calendar and ordered to be 
                                printed

_______________________________________________________________________

                               RESOLUTION

 
Providing for consideration of the bill (H.R. 5618) to continue Federal 
unemployment programs, and waiving a requirement of clause 6(a) of rule 
XIII with respect to consideration of certain resolutions reported from 
                        the Committee on Rules.

    Resolved, That upon the adoption of this resolution it shall be in 
order to consider in the House the bill (H.R. 5618) to continue Federal 
unemployment programs. All points of order against consideration of the 
bill are waived except those arising under clause 9 or 10 of rule XXI. 
The amendment printed in the report of the Committee on Rules 
accompanying this resolution shall be considered as adopted. The bill, 
as amended, shall be considered as read. All points of order against 
provisions in the bill, as amended, are waived. The previous question 
shall be considered as ordered on the bill, as amended, to final 
passage without intervening motion except: (1) one hour of debate 
equally divided and controlled by the chair and ranking minority member 
of the Committee on Ways and Means; and (2) one motion to recommit with 
or without instructions.
    Sec. 2.  The requirement of clause 6(a) of rule XIII for a two-
thirds vote to consider a report from the Committee on Rules on the 
same day it is presented to the House is waived with respect to any 
resolution reported through the legislative day of July 3, 2010.
                                                 House Calendar No. 209

111th CONGRESS

  2d Session

                              H. RES. 1495

                          [Report No. 111-519]

_______________________________________________________________________

                               RESOLUTION

Providing for consideration of the bill (H.R. 5618) to continue Federal 
unemployment programs, and waiving a requirement of clause 6(a) of rule 
XIII with respect to consideration of certain resolutions reported from 
                        the Committee on Rules.

_______________________________________________________________________

                             June 30, 2010

        Referred to the House Calendar and ordered to be printed
```
Exhibit 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with Amendment No. 1 to the Annual Report of Tribute Pharmaceuticals Canada Inc. (the "Company") on Form 10-K/A for the year ended December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Rob Harris, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1)     The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








June 5, 2013
By:
/s/ Rob HarrisRob HarrisChief Executive Officer